Enzyme therapy for Pompe disease: from science to industrial enterprise (Q34954692)

5 August 2017

1 reference

title

Enzyme therapy for Pompe disease: from science to industrial enterprise (English)

1 reference

5 August 2017

Arnold J J Reuser

1

1 reference

5 August 2017

Hannerieke Van Den Hout

2

1 reference

5 August 2017

Agnes G A Bijvoet

3

1 reference

5 August 2017

Marian A Kroos

4

1 reference

5 August 2017

Martin P Verbeet

5

1 reference

5 August 2017

Ans T Van Der Ploeg

6

1 reference

5 August 2017

13 August 2002

1 reference

European Journal of Pediatrics

5 August 2017

1 reference

5 August 2017

161 Suppl 1

1 reference

5 August 2017

S106-11

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02680006

5 August 2017

0 references

cites work

Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease

1 reference

https://api.crossref.org/works/10.1007%2FBF02680006

21 January 2018

Functions of lysosomes

1 reference

https://api.crossref.org/works/10.1007%2FBF02680006

A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680006

Isolation and characterisation of a recombinant, precursor form of lysosomal acid alpha-glucosidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680006

Enzyme therapy for Gaucher disease: the first 5 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680006

alpha-Glucosidase deficiency in generalized glycogenstorage disease (Pompe's disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680006

Bone marrow transplants in genetic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680006

Characterization of the human lysosomal alpha-glucosidase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680006

Production of pharmaceutical proteins from transgenic animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680006

Lysosomes in type II glycogenosis. Changes during administration of extract from Aspergillus niger

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680006

Enzyme-replacement therapy in mucopolysaccharidosis I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680006

Phosphohexosyl components of a lysosomal enzyme are recognized by pinocytosis receptors on human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680006

Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680006

Sequence of the cDNA and 5'-flanking region for human acid alpha-glucosidase, detection of an intron in the 5' untranslated leader sequence, definition of 18-bp polymorphisms, and differences with previous cDNA and amino acid sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680006

Isolation and Partial Characterization of the Structural Gene for Human Acid Alpha Glucosidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680006

Glycogenosis type II (acid maltase deficiency)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680006

Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680006

Recombinant human alpha-glucosidase from rabbit milk in Pompe patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680006

Prospect for enzyme therapy in glycogenosis II variants: a study on cultured muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680006

Intravenous administration of phosphorylated acid alpha-glucosidase leads to uptake of enzyme in heart and skeletal muscle of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680006

High-level production of recombinant human lysosomal acid alpha-glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680006

21 January 2018

Identifiers

DOI

10.1007/BF02680006

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference